Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; and vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
IPO Year:
Exchange: NYSE
Website: centene.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/5/2026 | $54.00 | Equal Weight → Overweight | Barclays |
| 10/14/2025 | $33.00 | Sell | Goldman |
| 7/28/2025 | $38.00 | Overweight → Neutral | Cantor Fitzgerald |
| 7/23/2025 | $30.00 | Overweight → Equal Weight | Wells Fargo |
| 7/21/2025 | $33.00 | Buy → Hold | TD Cowen |
| 7/16/2025 | $30.00 | Neutral → Underperform | BofA Securities |
| 7/10/2025 | $33.00 | Overweight → Equal-Weight | Morgan Stanley |
| 7/2/2025 | $45.00 | Buy → Neutral | UBS |
| 7/2/2025 | $48.00 | Overweight → Neutral | Analyst |
| 6/9/2025 | $70.00 | Overweight | Morgan Stanley |
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
3 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
Fastest customizable press release news feed in the world
FORT LAUDERDALE, Fla., April 7, 2026 /PRNewswire/ -- Sunshine Health, a company of Centene Corporation (NYSE:CNC), is proud to highlight the 2025 results of Sunshine Health Works, a comprehensive workforce development program designed to address critical labor shortages across Florida's healthcare system while creating clear pathways for individuals to enter, remain, and advance in healthcare careers. Since its launch, Sunshine Health Works has helped support and train nearly 1,900 people through partnerships with local colleges, healthcare providers, and community-based organiz
Appoints Daniel Finke to Group President, Markets and Commercial and Wellcare CEO Michael Carson to Group President, Medicare and Specialty ST. LOUIS, April 6, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced the creation of two new executive leadership positions, which will report to Chief Executive Officer Sarah London. Centene has hired Daniel Finke as Group President, Markets and Commercial, and appointed Michael Carson to Group President, Medicare and Specialty. "We are pl
Investment will support crisis care, transitional services and housing at the former St. Vincent Medical Center campusLOS ANGELES, April 2, 2026 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), is partnering with the Centene Foundation to invest $6 million to support the development of the St. Vincent Behavioral Health Campus. The campus will offer behavioral health services and housing to people experiencing mental health and substance abuse challenges. "Getting the right care at t
The combined organization will continue to serve Medicaid, Marketplace, Medicare and Behavioral Health and Intellectual/Developmental Disabilities Tailored Plan members statewideCHARLOTTE, N.C., April 2, 2026 /PRNewswire/ -- Carolina Complete Health and WellCare of North Carolina, subsidiaries of the Centene Corporation (NYSE:CNC), today announced [receipt of regulatory approval] to close on their merger. The organization will operate under the Carolina Complete Health brand and serve more than 980,000 members across Medicaid, Medicare and Marketplace. Carolina Complete Health will also continue to support all four Behavioral Health and Intellectual/Developmental Disabilities (I/DD) Tailored
RIDGELAND, Miss., April 1, 2026 /PRNewswire/ -- Magnolia Health, a company of Centene Corporation (NYSE:CNC), today announced a donation of $2 million to Joyce's Village of Hope project in Warren County to expand housing and support services for women and children transitioning out of domestic violence shelters. The program is operated by the Mississippi Center for Police & Sheriffs (MSCPS) and aims to help families move from crisis to stability. Through this funding, MSCPS will expand supportive housing by developing eight homes dedicated to women and children exiting domestic
Health Net commits $1 million to public information effort to help eligible residents maintain Medi-Cal coverage under new federal and state rulesSACRAMENTO, Calif., April 1, 2026 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), is launching "Get Informed, Stay Covered," a campaign to educate Medi-Cal enrollees about critical changes to federal and state eligibility rules. A 2025 federal law requires certain adults eligible for Medi-Cal to meet new work or community engagement stand
FORT LAUDERDALE, Fla., March 31, 2026 /PRNewswire/ -- Sunshine Health, a company of Centene Corporation (NYSE:CNC), has awarded $100,000 in childcare and transportation grants to five nonprofit organizations across Florida. The grants connect vulnerable Floridians in more than 40 counties with reliable transportation and affordable childcare, helping reduce barriers to employment. "We are proud to partner with nonprofit organizations that are creating practical, sustainable solutions to help people build stronger futures for themselves and their families," said Charlene Zein, Pr
In the news release, Delaware First Health and the Centene Foundation Announce Grant Program Open Submission Period, issued 27-Mar-2026 by Delaware First Health over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows: Delaware First Health and the Centene Foundation Announce Grant Program Open Submission Period Community-based organizations and providers across Delaware can apply for funding now through May 25, 2026NEWARK, Del., March 27, 2026 /PRNewswire/ -- Delaware First Health ("DFH"), a leading Medicaid managed care organization in Delaware, and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), t
Community-based organizations and providers across Delaware can apply for funding now through May 25, 2026NEWARK, Del., March 27, 2026 /PRNewswire/ -- Delaware First Health ("DFH"), a leading Medicaid managed care organization in Delaware, and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), today announced an open submission period for grants that will be provided to non-profit, community-based organizations and providers that address drivers of health. By addressing these conditions—such as lack of access to healthy food, housing insecurity and transportation accessibility—these grants will improve the lives and health of Delawareans.
Program to support eligible Medicaid enrollees with diabetes in rural Kentucky with tailored initiatives to support nutrition security and chronic disease managementHAZARD, Ky., March 18, 2026 /PRNewswire/ -- WellCare of Kentucky and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), today announced an investment of $550,000 to launch the WellCare Food is Medicine Program ("the Program") to address diabetes-related needs in rural communities throughout Eastern Kentucky. The Program builds on an existing nutrition security-related partnership with Mountain Comprehensive Health Corporation (MCHC), a Kentucky-based rural community health center, and Community Agricultu
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Barclays upgraded Centene from Equal Weight to Overweight and set a new price target of $54.00
Goldman initiated coverage of Centene with a rating of Sell and set a new price target of $33.00
Cantor Fitzgerald downgraded Centene from Overweight to Neutral and set a new price target of $38.00
Wells Fargo downgraded Centene from Overweight to Equal Weight and set a new price target of $30.00
TD Cowen downgraded Centene from Buy to Hold and set a new price target of $33.00
BofA Securities downgraded Centene from Neutral to Underperform and set a new price target of $30.00
Morgan Stanley downgraded Centene from Overweight to Equal-Weight and set a new price target of $33.00
Analyst downgraded Centene from Overweight to Neutral and set a new price target of $48.00
UBS downgraded Centene from Buy to Neutral and set a new price target of $45.00
Morgan Stanley resumed coverage of Centene with a rating of Overweight and set a new price target of $70.00
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
SCHEDULE 13G/A - CENTENE CORP (0001071739) (Subject)
DEFA14A - CENTENE CORP (0001071739) (Filer)
DEF 14A - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
10-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
SCHEDULE 13G/A - CENTENE CORP (0001071739) (Subject)
10-Q - CENTENE CORP (0001071739) (Filer)
Live finance-specific insights
-- 2025 Full Year GAAP Diluted Loss Per Share of $(13.53); Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater than $3.00 -- Consolidated HBR of 94.3% in the fourth quarter of 2025, which includes a Commercial HBR of 95.4% that was 100 basis points higher than expectations driven by net out of period items.Medicaid HBR of 93.0% in the fourth quarter of 2025, reflecting continued progress and representing 40 basis points of sequential improvement compared to the third quarter.Fundamental fourth quarter 2025 trend was consistent with expectations in Medicaid and Medicare Advantage, and slightly favorable in Marketplace and Medicare PD
ST. LOUIS, Jan. 13, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Friday, February 6, 2026, and host a conference call at 9:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 2815529 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under
-- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 -- Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10 benefit of a low adjusted effective tax rate in the quarter as compared to the expected full year adjusted effective tax rate of 20-21%.$6.7 billion non-cash goodwill impairment, resulting in a GAAP loss and corresponding reduction of retained earnings in the third quarter of 2025. After the reduction to retained earnings, the debt-to-capital ratio was 45.5% at September 30, 2025.Medicaid HBR of 93.4% in the third quarter, including an approximate 40 basis point benefit from a retroactive revenue adjustment attributed to the
ST. LOUIS, Sept. 29, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 third quarter financial results at approximately 6:00 a.m. ET on Wednesday, October 29, 2025, and host a conference call at 9:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 0266211 to ex
-- Diluted Loss Per Share of $(0.51); Adjusted Diluted Loss Per Share of $(0.16) -- ST. LOUIS, July 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the second quarter ended June 30, 2025. In summary, the 2025 second quarter results were as follows: Total revenues (in millions) $ 48,742 Premium and service revenues (in millions) $ 42,467 Health benefits ratio 93.0 % SG&A expense ratio 7.1 % Adjusted SG&A expense ratio (1) 7.1 % GAAP diluted loss per share $ (0.51) Adjusted diluted loss per share (1) $ (0.16) Total cash flow provided by operations (in millions) $
CALL MOVED TO 8AM ET ST. LOUIS, July 22, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 second quarter financial results at approximately 6:00 a.m. ET on Friday, July 25, 2025, and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 7878291 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com,
-- Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 -- First quarter 2025 adjusted diluted EPS of $2.90, up 28% from $2.26 in the first quarter of 2024.17% year-over-year premium and service revenue growth.Membership increases of 29% in Marketplace and 22% in Medicare PDP, compared to the first quarter of 2024.Increased 2025 premium and service revenues guidance by $6.0 billion driven by outperformance in Marketplace enrollment and Medicare member retention.ST. LOUIS, April 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the first quarter ended March 31, 2025. In summary, the 2025 first quarter results were as follows: Total
ST. LOUIS, March 18, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 first quarter financial results at approximately 6:00 a.m. ET on Friday, April 25, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9776439 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors
-- 2024 Full Year Diluted EPS of $6.31; Adjusted Diluted EPS of $7.17 -- 2024 adjusted diluted EPS of $7.17, up 7% from $6.68 in 2023.Membership increases of 12% in Marketplace and 50% in Medicare PDP, compared to the fourth quarter of 2023.Executed on capital deployment with $3.0 billion of share repurchases in 2024.Increased 2025 premium and service revenues guidance by $4.0 billion driven by Medicaid revenue and better than expected membership performance during the annual enrollment period in Medicare Advantage and PDP.ST. LOUIS, Feb. 4, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the fourth quarter and year ended December
ST. LOUIS, Jan. 15, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Tuesday, February 4, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 1342288 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, unde
Live Leadership Updates
Appoints Daniel Finke to Group President, Markets and Commercial and Wellcare CEO Michael Carson to Group President, Medicare and Specialty ST. LOUIS, April 6, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced the creation of two new executive leadership positions, which will report to Chief Executive Officer Sarah London. Centene has hired Daniel Finke as Group President, Markets and Commercial, and appointed Michael Carson to Group President, Medicare and Specialty. "We are pl
Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t
Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO
ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g
New leadership role reflects Centene's focus on ICHRA growth ST LOUIS, Jan. 9, 2025 /PRNewswire/ -- Centene Corporation ("Centene") (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, is pleased to announce that Alan Silver has joined the organization as the President of its Ambetter Health Solutions business, which focuses on ICHRA (Individual Coverage Health Reimbursement Arrangements). This newly created role reflects Centene's belief that consumers increasingly will seek health insurance that offers transparency, customization, choice and convenience. ICHRA plans allow employees to shop on the individual Marketplace and choose the insurance plan
PEMBROKE PINES, Fla., Nov. 7, 2024 /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE:CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024. Zein has nearly two decades of experience in the healthcare industry, including various leadership roles of increasing scope and responsibility at Sunshine Health since joining in 2019. She most recently served as Sunshine Health Chief Product President, where she had oversight of all of Sunshine Health's Medi
ST. LOUIS, Aug. 15, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today that it has appointed Thomas R. Greco to the Centene Board of Directors, effective Aug. 9, 2024. Mr. Greco's term will run through the Company's 2025 annual meeting of stockholders. The appointment of Mr. Greco expands Centene's Board of Directors to 11 members. Mr. Greco is a seasoned operator and executive who brings more than four decades of public company leadership and expertise to Centene. Over the course of his career, he has implemented growth strategies and fostered
TAMPA, Fla., July 31, 2024 /PRNewswire/ -- Big Brothers Big Sisters of America (BBBSA), the nation's preeminent one-to-one youth mentoring organization, today announced the election of its newest Board member, Centene Corporation [Centene] (NYSE:CNC) Executive Vice President (EVP) of External Affairs, Jonathan Dinesman. Centene, a leading healthcare enterprise focused on transforming the health of the communities it serves, has been a long-time partner of BBBSA. Dinesman oversees Federal and State Government Relations; Centene's political action committee; Public Policy; Strat
Current Wellcare President & CEO, Richard Fisher, will join the Operations leadership team under Centene Chief Operating Officer Susan Smith, bringing additional Medicare expertise into Centene's core services operations ST. LOUIS, Jan. 22, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced two appointments. Michael A. Carson joins Centene as President and Chief Executive Officer (CEO) of its Medicare business, Wellcare. Mr. Carson will be responsible for Medicare business performance, strategy and growth and will report to Centene President Ken Fasola. Carson succeeds Richard Fisher, who has
PA Health & Wellness Safe & Sound Program to provide assistance with critical home repairs in Greater Harrisburg area HARRISBURG, Pa., Dec. 11, 2023 /PRNewswire/ -- PA Health & Wellness (PHW), a wholly owned subsidiary of Centene Corporation (NYSE:CNC), and Centene Foundation, the philanthropic arm of Centene Corporation, today announced its new partnership with Habitat for Humanity of the Greater Harrisburg Area to provide critical home repairs to area homeowners as part of the organization's Critical Home Repair program. The new program – PHW Safe & Sound – will cover the cost of eligible interior and exterior structural, electrical, plumbing, HVAC and other critical home repairs so that
This live feed shows all institutional transactions in real time.
SC 13G - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)